Liquid purification or separation – Filter – Material
Reexamination Certificate
2005-06-21
2005-06-21
Fortuna, Ana (Department: 1723)
Liquid purification or separation
Filter
Material
C210S500270, C210S088000, C210S500360, C210S500420, C210S490000
Reexamination Certificate
active
06908553
ABSTRACT:
Membranes and methods for making membranes are disclosed. The membranes include a polymeric matrix and a particulate material immobilized within the matrix. The membranes may find particular application in methods and apparatus for removing organic compounds from a biological fluid as part of a pathogen inactivation treatment.
REFERENCES:
patent: 3158532 (1964-11-01), Pall
patent: 3238056 (1966-03-01), Pall, et al.
patent: 3746175 (1973-07-01), Markley
patent: 3908044 (1975-09-01), Gunning
patent: 3996131 (1976-12-01), Conn
patent: 4011871 (1977-03-01), Taft
patent: 4384954 (1983-05-01), Nakashima et al.
patent: 4610792 (1986-09-01), Van Gils et al.
patent: 4693981 (1987-09-01), Wiesehahn et al.
patent: 4728432 (1988-03-01), Sugiyama et al.
patent: 4735193 (1988-04-01), Kulprathipanja et al.
patent: 4748120 (1988-05-01), Wiesehahn
patent: 4777069 (1988-10-01), Cederberg et al.
patent: 4957943 (1990-09-01), McAllister et al.
patent: 5071610 (1991-12-01), Hagen et al.
patent: 5092990 (1992-03-01), Muramatsu et al.
patent: 5102547 (1992-04-01), Waite et al.
patent: 5197208 (1993-03-01), Lapidus
patent: 5277820 (1994-01-01), Ash
patent: 5312576 (1994-05-01), Swei et al.
patent: 5472607 (1995-12-01), Mailvaganam et al.
patent: 5505841 (1996-04-01), Pirbazari et al.
patent: 5559250 (1996-09-01), Cook et al.
patent: 5639376 (1997-06-01), Lee et al.
patent: 5660731 (1997-08-01), Piechocki et al.
patent: 5660903 (1997-08-01), Andersen et al.
patent: 5691132 (1997-11-01), Wollowitz et al.
patent: 5700902 (1997-12-01), Hancock et al.
patent: 5714521 (1998-02-01), Kedem et al.
patent: 5795483 (1998-08-01), Ung-Chhun et al.
patent: 5914039 (1999-06-01), Mahendran et al.
patent: 6090441 (2000-07-01), Vining, Jr. et al.
patent: 6099734 (2000-08-01), Boggs et al.
patent: 6126826 (2000-10-01), Pacheco et al.
patent: 6200474 (2001-03-01), Kopaciewicz et al.
patent: 6513666 (2003-02-01), Meyering et al.
patent: 99 93 1933 (2002-12-01), None
patent: WO 91/08826 (1991-06-01), None
patent: 97/07674 (1997-03-01), None
patent: 97/37536 (1997-10-01), None
patent: 98/30327 (1998-07-01), None
PCT Written Opinion mailed Jul. 27, 2000 in PCT/US99/14471.
International Search Report for PCT/US99/14471, dated Sep. 13, 1999.
Nakano, “Effects of Interaction with Surfactants, Adsorbents, and Other Substances on the Permeation of Chlorpromzaine through a Dimethyl Polysiloxane Membrane,”Journal of Pharmaceutical Sciences, vol. 60, No. 4, pp. 571-575, Apr. 1971.
E. Denti et al., “Adsorption Characteristics of Cellulose Acetate Coated Charcoals,”J. Biomed. Mater. Res., vol. 9, pp. 143-140 (1975).
E. Denti et al., “Evaluation of novel sorbent systems for joint hemodialysis and hemoperfusion,”Medical Instrumentation, vol. 11, No. 4, pp. 212-216, Jul.-Aug. 1977.
P.S. Malchesky et al., “Membranes Containing Sorbets for Blood Detoxification,” vol. XXIIITrans.Am.Soc.Artif.Intern. Organs, pp. 659-665, 1977.
P.S. Malchesky et al., “Sorbent Membranes: Device Designs, Evaluations and Potential Applications,”Artificial Organs, vol. 2, No. 4, pp. 367-371, Nov. 1978.
Tijssen et al., “A Hemoperfusion Column Based on Activated Carbon Granules Coated with an Ultrathin Membrane of Cellulose Acetate”,Artificial Organs, vol. 3, No. 1, pp. 11-14, Feb., 1979.
L.B. Santamaria et al.,Rianimazione, “L'emoperfusione mediante carbone attivato nel trattamento delle tossicopatie esogene acute,”Minerva Anestesiologica, Min. Anest., 47, pp. 185-192, 1981.
Mori et al., “Permeability of heparinized hydrohilic polymer (H-RSD): Application to semipermeable membrane for microencapsulation of activated charcoal,”Journal of Biomedical Materials Research, vol. 16, pp. 17-30, (1982).
Erhan Piskin et al., “The Past Present and Future of Artificial Organs,”International Symposium on Hemoperfusin and Artificial Organs, 4th, Ankara, 1982.
Helen E. Kambic et al., “Historical Perspective Therapeutic Applications and New Frontiers,”The International Center for Artificial Organs and Transplantation, Plasmapheresis (Brochure), Copyright 1983.
T.M.S. Chang et al., “Effect of Desferrioxamine on Removal of Aluminium and Iron by Coated Charcoal Haemoperfusion and Haemodialysis,”The Lancet, pp. 1051-1053, Nov. 5, 1983.
Lopatikin et al., “Plasmapherese in der Komplexherapie bei Patienten mit akuter Pyelonephritis und Urosepsis,”Z. Urol. Nephrol., 79, pp. 317-324, (1986) H. 6.
Oka, “The Possibility of Improving Bioocompatibility by Removing Anaphylatoxins from the Circuit of Blood-Perfused Artifical Organs,” vol. XXVTrans Am Soc Artif Intern Organs, pp. 778-783, 1989.
C.P. Ramos, M.D. et al., “Hemodialysis-Hemopefusion in Fulminant Viral Hepatitis,”Biomat., Art. Cells, Art. Org., 18(5), pp. 689-692, (1990).
E. Ben-Hur, “Inhibition of Phthalocyanine-Sensitized Photohemolysis of Human Erythroytes by Quercetin,”Photochemistry and Photobiology, vol. 57, No. 6, pp. 984-988, 1993.
S. Rywkin et al., “New Phthalocyanines for Photodynamic Virus Inactivation in Red Blood Cell Concentrates,”Photochemsitry and Photobiology, vol. 60, No. 2, pp. 165-170, 1994.
E. Ben Hur et al., “Virus inactivation in red cell concentrates by photosensitization with phthalocyanines: protection red cells but not of vesicular stomatitis virus with a water-soluble analogue of vitamin E,”Transfusion, vol. 35, No. 5, pp. 401-406, 1995.
S. Rywkin et al., “Selective protection against IgG binding to red cells treated with phthalocyanines and red light for virus inactivation,”Transfusion, vol. 35, No. 5, pp. 414-420, 1995.
H. Margolis-Nunno et al., “Elimination of potential mutagencity in platelet concentrates that are virally inactivated with psoralens and ultraviolet A light,”Transfusion, vol. 35, No. 10, pp. 855-862, 1995.
Stephen J. Wagner et al., “Factors Affecting Virus Photoinactivation by a Series of Phenothiazine Dyes,”Photochemistry and Photobiology, 67(3), pp. 343-349, 1998.
E. Ben-Hur et al., “Photodynamic decontamination of blood for transfusion,”New York Blood Center.
“Measuring the Adsorption Capacity of Powdered Activated Carbon,”American Norit Company, Inc.,Brochure.
“Preparation of natural essential oils free from psoralen cpds.—by contacting oils with water-insol. porous synthetic adsorbing resin e.g. spherical resin of polystyrene-polydivinyl benzene polymer,” Abstract, AN 88-023972, JP 6228319B A (Hasegawa Co. Ltd. ) Dec. 9, 1987.
Boggs Daniel R.
McLarty Donna L.
Pauley Robin G.
Sternberg Shmuel
Baxter International Inc.
Fortuna Ana
Kolomayets A. G.
Price B. R. L.
Reagen J. P.
LandOfFree
Composite membrane with particulate matter substantially... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composite membrane with particulate matter substantially..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composite membrane with particulate matter substantially... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3496488